Oncofetal Fibronectin in Diabetic Retinopathy

Investigative Ophthalmology and Visual Science

Volumn 45, Issue 1, 2004, Pages 287-295

  Khan, Zia A ^a   Cukiernik, Mark ^a   Gonder, John R ^a   Chakrabarti, Subrata ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; FIBRONECTIN; GLUCOSE; ONCOFETAL FIBRONECTIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ADULT; AGED; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CLINICAL ARTICLE; DIABETIC RETINOPATHY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN VARIANT; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STREPTOZOCIN DIABETES; VITREOUS BODY;

AGED; ANIMALS; BLOTTING, WESTERN; CELL DIVISION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIN-1; ENDOTHELIUM, VASCULAR; FEMALE; FIBRONECTINS; GENE SILENCING; HUMANS; MALE; MIDDLE AGED; RATS; RATS, SPRAGUE-DAWLEY; RETINAL PERFORATIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SULFONAMIDES; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION; VITRECTOMY; VITREOUS BODY;

EID: 0347358071     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.03-0540     Document Type: Article

References (50)

1. Caird FI. The epidemiology of diabetic microangiopathy. Acta Diabetol Lat. 1971;8:240-248.
2. Mazze RS, Sinnock P, Deeb L, Brimberry JL. An epidemiological model for diabetes mellitus in the United States: five major complications. Diabetes Res Clin Pract. 1985;1:185-191.
3. King GL, Brownlee M. The cellular and molecular mechanisms of diabetic complications. Endocrinol Metab Clin North Am. 1996;25:255-270.
4. Koya D, King GL. Protein kinase C activation and the development of diabetic complications. Diabetes. 1998;47:859-866.
5. Ljubimov AV, Burgeson RE, Butkowski RJ, et al. Basement membrane abnormalities in human eyes with diabetic retinopathy. J Histchem Cytochem. 1996;44:1469-1479.
6. Evans T, Deng DX, Chakrabarti S. Endothelin receptor blockade prevents augmented extracellular matrix protein component mRNA expression and capillary basement membrane thickening in the retina of diabetic and galactose fed rats. Diabetes. 2000;49:662-666.
7. Roy S, Cagliero E, Lorenzi M. Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci. 1996;37:258-266.
8. Yamada KM. Cell surface interactions with extracellular materials. Annu Rev Biochem. 1983;52:761-799.
9. Kornblihtt AR, Umezawa K, Vibe-Pedersen K, Baralle FE. Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J. 1996;4:1755-1759.
10. Jaffe EA, Mosher DF. Synthesis of fibronectin by cultured human endothelial cells. Ann N Y Acad Sci. 1978;312:122-131.
11. Gutman A, Kornblihtt AR. Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc Natl Acad Sci USA. 1987;84:7179-7182.
12. Mandel U, Hamilton Therkildsen M, Reibel J, et al. Cancer-associated changes in glycosylation of fibronectin: immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies. APMIS. 1992;100:817-826.
13. Jarnagin WR, Rockey DC, Koteliansky VE, Wang S, Bissell DM. Expression of variant fibronectins in wound healing: cellular source and biological activity of the EIIIA segment in rat hepatic fibrogenesis. J Cell Biol. 1994;127:2037-2048.
14. Norton PA, Hynes RO. Alternative splicing of chicken fibronectin in embryos and in normal and transformed cells. Mol Cell Biol. 1987;7:4297-4307.
15. Oyama F, Hirohashi S, Shimosato Y, Titani K, Sekiguchi K. Deregulation of alternative splicing of fibronectin pre-mRNA in malignant human liver tissues. J Biol Chem. 1989;264:10331-10334.
16. Colombi M, Barlati S, Kornblihtt A, Baralle FE, Vaheri A. A family of fibronectin mRNAs in human normal and transformed cells. Biochem Biophys Acta. 1986;868:207-214.
17. Zardi L, Carnemolla B, Siri A, et al. Transformed human cells produce a new fibronectin isoform by preferential alternative splicing of a previously unobserved exon. EMBO J. 1987;6:2337-2342.
18. Demartis S, Tarli L, Borsi L, Zardi L, Neri D. Selective targeting of tumour neovasculature by a radiohalogenated human antibody fragment specific for the ED-B domain of fibronectin. Eur J Nucl Med. 2001;28:534-539.
19. Castellani P, Dorcaratto A, Pau A, et al. The angiogenesis marker ED-B+ fibronectin isoform in intracranial meningiomas. Acta Neurochir. 2000;142:277-282.
20. Nickeleit V, Kaufman AH, Zagachin L, Dutt JE, Foster CS, Colvin RB. Healing corneas express embryonic fibronectin isoforms in the epithelium, subepithelial stroma, and endothelium. Am J Pathol. 1996;149:549-558.
21. Borsi L, Castellani A, Risso AM, Leprini A, Zardi L. Transforming growth factor-β regulates the splicing pattern of fibronectin messenger RNA precursor. FEBS Lett. 1990;261:175-178.
22. Balza E, Borsi L, Allemanni G, Zardi L. Transforming growth factor β regulates the level of different fibronectin isoforms in normal human cultured fibroblasts. FEBS Lett. 1998;228:42-44.
23. Shankland SJ, Scholey JW. Expression of transforming growth factor 1 during diabetic renal hypertrophy. Kidney Int. 1994;42:430-442.
24. Pat A. Clinical and experimental studies on retinal neovascularization. Am J Ophthalmol. 1982;94:715-743.
25. Chen S, Evans T, Deng D, Cukiernik M, Chakrabarti S. Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins. Nephron. 2002;90:86-94.
26. Cai L, Chen S, Evans T, Cherian MG, Chakrabarti S. Endothelin-1-mediated alteration of metallothionein and trace metals in the liver and kidneys of chronically diabetic rats. Int J Exp Diabetes Res. 2002;3:193-198.
27. Chen S, Mukherjee S, Chakraborty C, Chakrabarti S. High glucose induced, endothelin-dependent fibronectin synthesis is mediated via NF-kappa B and AP-1. Am J Physiol. 2003;284:C263-C272.
28. Zakrajsek BA, Schmittgen TD. Effect of experimental treatment on housekeeping gene expression: validation by real-time, quantitative RT-PCR. J Biochem Biophys Methods. 2000;46:69-81.
29. Vasir B, Reitz P, Xu G, Sharma A, Bonner-Weir S, Weir GC. Effects of diabetes and hypoxia on gene makers of angiogenesis (HGF, cMET, uPA and uPAR, TGF-α TGF-β, bFGF and Vimentin) in cultured and transplanted rat islets. Diabetologia. 2000;43:763-772.
30. Kofron M, Demel T, Xanthos J, et al. Mesoderm induction in Xenopus is a zygotic event regulated by maternal VegT via TGFβ growth factors. Development. 1999;126:5759-5770.
31. Hammond SM, Boettcher S, Caudy AA, Kobayashi R, Hannon GJ. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science. 2001;293:1146-1150.
32. Scudiero DA, Shoemaker RH, Paull KD, et al. Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res. 1988;48:4827-4833.
33. Chen S, Apostolova MD, Cherian MG, Chakrabarti S. Interaction of endothelin-1 with vasoactive factors in mediating glucose-induced increased permeability in endothelial cells. Lab Invest. 2000;80:1311-1321.
34. Hsueh WA, Anderson PW. Hypertension, the endothelial cell, and vascular complications of diabetes mellitus. Hypertension. 1992;20:253-263.
35. Midulla M, Verma R, Pignatelli M, Ritter MA, Courtenay-Luck NS, George AJ. Source of oncofetal ED-B-containing fibronectin: implications of production by both tumor and endothelial cells. Cancer Res. 2000;60:164-169.
36. Casaroli Marano RP, Preissner KT, Vilaro S. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp Eye Res. 1995;60:5-17.
37. Alessandri G, Chirivi RG, Castellani P, Nicolo G, Giavazzi R, Zardi L. Isolation and characterization of human tumor-derived capillary endothelial cells: role of oncofetal fibronectin. Lab Invest. 1998;78:127-128.
38. Manabe R, Oh-e N, Maeda T, Fukuda T, Sekiguchi K. Modulation of cell-adhesive activity of fibronectin by alternatively spliced EDA segment. J Cell Biol. 1997;139:295-307.
39. Hashimoto-Uoshima M, Yan YZ, Schneider G, Aukhil I. The alternatively spliced domains EIIIB and EIIIA of human fibronectin affect cell adhesion and spreading. J Cell Sci. 1997;100:2271-2280.
40. Carnemolla B, Leprini A, Allemanni G, Saginati M, Zardi L. The inclusion of the type III repeat ED-B in the fibronectin molecule generates conformational modifications that unmask a cryptic sequence. J Biol Chem. 1992;267:24689-24692.
41. Cai L, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 2002;16:242-260.
42. Forrester JV, Shafiee A, Schroder S, Knott R, McIntosh L. The role of growth factors in proliferative diabetic retinopathy. Eye. 1993;7:276-287.
43. Deng DX, Evans T, Mukherjee K, Downey D, Chakrabarti S. Diabetes induced vascular dysfunction in the retina: role of endothelins. Diabetologia. 1999;42:1228-1234.
44. Border WA, Noble NA. Transforming growth factor-β in tissue fibrosis. N Engl J Med. 1994;331:1286-1292.
45. B gene expression in chronic diabetes. Curr Eye Res. 1998;17:301-307.
46. Chakrabarti S, Sima AAF. Endothelin-1 and endothelin-3 like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats. Diab Res Clin Prac. 1997;37:109-120.
47. Brown MR, Vaughan J, Jimenez LL, Vale W, Baird A. Transforming growth factor-beta: role in mediating serum-induced endothelin production by vascular endothelial cells. Endocrinology. 1991;129:2355-2360.
48. Kurihara H, Yoshizumi M, Sugiyama T, et al. Transforming growth factor-beta stimulates the expression of endothelin mRNA by vascular endothelial cells. Biochem Biophys Res Commun. 1989;159:157-162.
49. Kim SJ, Angel P, Lafyatis R, et al. Autoinduction of transforming growth factor-beta 1 is mediated by the AP-1 complex. Mol Cell Biol. 1990;10:1492-1497.
50. Kim SJ, Jeang KT, Glick AB, Sporn MB, Roberts AB. Promoter sequences of the human transforming growth factor-beta 1 gene responsive to transforming growth factor-beta 1 autoinduction. J Biol Chem. 1989;264:7041-7045.